ev3 Expanding Vascular Presence Via $95 Mil. IntraTherapeutics Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Private equity investor Warburg Pincus' ev3, Inc. unit is looking to build its peripheral vascular disease business through the purchase of Centerpulse subsidiary IntraTherapeutics for $95 mil. cash